| Literature DB >> 34071065 |
Jean-Frédéric LeBlanc1, Jonathan P Segal2, Lucia Maria de Campos Braz1,3, Ailsa L Hart1,3.
Abstract
The gut microbiome has been implicated in a range of diseases and there is a rapidly growing understanding of this ecosystem's importance in inflammatory bowel disease. We are yet to identify a single microbe that causes either ulcerative colitis (UC) or pouchitis, however, reduced microbiome diversity is increasingly recognised in active UC. Manipulating the gut microbiome through dietary interventions, prebiotic and probiotic compounds and faecal microbiota transplantation may expand the therapeutic landscape in UC. Specific diets, such as the Mediterranean diet or diet rich in omega-3 fatty acids, may reduce intestinal inflammation or potentially reduce the risk of incident UC. This review summarises our knowledge of gut microbiome therapies in UC and pouchitis.Entities:
Keywords: ileoanal pouch inflammatory bowel disease; microbiota; ulcerative colitis
Year: 2021 PMID: 34071065 DOI: 10.3390/nu13061780
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717